Swinton Paul A, Shim Joanna S C, Pavlova Anastasia Vladimirovna, Moss Rachel, Maclean Colin, Brandie David, Mitchell Laura, Greig Leon, Parkinson Eva, Tzortziou Brown Victoria, Morrissey Dylan, Alexander Lyndsay, Cooper Kay
School of Health Sciences, Robert Gordon University, Aberdeen, UK.
Library Services, Robert Gordon University, Aberdeen, UK.
BMJ Open Sport Exerc Med. 2023 Feb 27;9(1):e001389. doi: 10.1136/bmjsem-2022-001389. eCollection 2023.
To quantify and describe effect size distributions from exercise therapies across a range of tendinopathies and outcome domains to inform future research and clinical practice through conducting a systematic review with meta-analysis.
Systematic review with meta-analysis exploring moderating effects and context-specific small, medium and large thresholds.
Randomised and quasi-randomised controlled trials involving any persons with a diagnosis of rotator cuff, lateral elbow, patellar, Achilles or gluteal tendinopathy of any severity or duration.
Common databases, six trial registries and six grey literature databases were searched on 18 January 2021 (PROSPERO: CRD42020168187). Standardised mean difference (SMD) effect sizes were used with Bayesian hierarchical meta-analysis models to calculate the 0.25 (small), 0.5 (medium) and 0.75 quantiles (large) and compare pooled means across potential moderators. Risk of bias was assessed with Cochrane's Risk of Bias tool.
Data were obtained from 114 studies comprising 171 treatment arms 4104 participants. SMD effect sizes were similar across tendinopathies but varied across outcome domains. Greater threshold values were obtained for self-reported measures of pain (small=0.5, medium=0.9 and large=1.4), disability (small=0.6, medium=1.0 and large=1.5) and function (small=0.6, medium=1.1 and large=1.8) and lower threshold values obtained for quality of life (small=-0.2, medium=0.3 and large=0.7) and objective measures of physical function (small=0.2, medium=0.4 and large=0.7). Potential moderating effects of assessment duration, exercise supervision and symptom duration were also identified, with greater pooled mean effect sizes estimated for longer assessment durations, supervised therapies and studies comprising patients with shorter symptom durations.
The effect size of exercise on tendinopathy is dependent on the type of outcome measure assessed. Threshold values presented here can be used to guide interpretation and assist with further research better establishing minimal important change.
通过进行一项荟萃分析的系统评价,量化并描述一系列肌腱病和结局领域中运动疗法的效应量分布,为未来的研究和临床实践提供参考。
进行荟萃分析的系统评价,探索调节效应以及特定背景下的小、中、大效应阈值。
涉及任何诊断为肩袖、外侧肘部、髌腱、跟腱或臀肌肌腱病的患者,病情严重程度和病程不限的随机和半随机对照试验。
于2021年1月18日检索了常见数据库、六个试验注册库和六个灰色文献数据库(PROSPERO:CRD42020168187)。使用标准化均数差(SMD)效应量,通过贝叶斯分层荟萃分析模型计算0.25(小)、0.5(中)和0.75分位数(大),并比较潜在调节因素的合并均值。采用Cochrane偏倚风险工具评估偏倚风险。
数据来自114项研究,包括171个治疗组,共4104名参与者。不同肌腱病的SMD效应量相似,但在结局领域有所不同。自我报告的疼痛(小=0.5,中=0.9,大=1.4)、残疾(小=0.6,中=1.0,大=1.5)和功能(小=0.6,中=1.1,大=1.8)测量获得的阈值较高,而生活质量(小=-0.2,中=0.3,大=0.7)和身体功能客观测量(小=0.2,中=0.4,大=0.7)获得的阈值较低。还确定了评估持续时间、运动监督和症状持续时间的潜在调节效应,评估持续时间更长、采用监督疗法以及纳入症状持续时间较短患者的研究,估计的合并平均效应量更大。
运动对肌腱病的效应量取决于所评估的结局指标类型。此处给出的阈值可用于指导解释,并有助于进一步开展研究,更好地确定最小重要变化。